AZP2006 in Parkinson’s disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex

Noelle Callizot, Georgia Culley, Grace Flower, Laura Rouvière, Véronique De Conto, Alexandre Wojcinski, Catherine Botto, Cecilia Estrella · 2026

Read AZP2006 in Parkinson’s disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex by Noelle Callizot, Georgia Culley, Grace Flower, Laura Rouvière, Véronique De Conto, Alexandre Wojcinski, Catherine Botto, Cecilia Estrella (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0359269.txt.

Description

Callizot and seven co-authors published a 2026 PLOS ONE study on a possible new drug for Parkinson's disease. The compound, called AZP2006, was tested in lab models of the disease. The title calls it a promising protective treatment for nerve cells. Its action involves lysosomes, the cell's cleanup units, and a protein pair named progranulin and prosaposin. New ways to slow Parkinson's are badly needed.

Catalog record

CREATORNoelle Callizot, Georgia Culley, Grace Flower, Laura Rouvière, Véronique De Conto, Alexandre Wojcinski, Catherine Botto, Cecilia Estrella
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51054
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0359269

Browse the full library · About the Tower of Babel